ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 127 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,389,247 | +2.9% | 1,336,672 | -0.2% | 0.01% | +12.5% |
Q2 2023 | $26,609,753 | +22.1% | 1,339,159 | +5.2% | 0.01% | +14.3% |
Q1 2023 | $21,796,141 | +98601.0% | 1,272,494 | +12.8% | 0.01% | 0.0% |
Q4 2022 | $22,083 | -99.8% | 1,128,361 | +27.7% | 0.01% | +40.0% |
Q3 2022 | $14,099,000 | +134.5% | 883,569 | +102.2% | 0.01% | +150.0% |
Q2 2022 | $6,012,000 | -8.7% | 436,995 | +5.2% | 0.00% | 0.0% |
Q1 2022 | $6,586,000 | -21.9% | 415,265 | +7.5% | 0.00% | -33.3% |
Q4 2021 | $8,438,000 | -24.6% | 386,439 | +3.2% | 0.00% | -25.0% |
Q3 2021 | $11,193,000 | -49.2% | 374,456 | -24.7% | 0.00% | -42.9% |
Q2 2021 | $22,024,000 | +61.0% | 497,310 | +61.3% | 0.01% | +40.0% |
Q1 2021 | $13,677,000 | -25.8% | 308,290 | -8.2% | 0.01% | -28.6% |
Q4 2020 | $18,429,000 | +135.0% | 336,006 | -2.0% | 0.01% | +133.3% |
Q3 2020 | $7,841,000 | +10.2% | 343,012 | +0.9% | 0.00% | 0.0% |
Q2 2020 | $7,115,000 | +85.1% | 339,908 | +23.4% | 0.00% | +50.0% |
Q1 2020 | $3,843,000 | -34.0% | 275,486 | +7.7% | 0.00% | 0.0% |
Q4 2019 | $5,825,000 | +256.9% | 255,908 | +82.7% | 0.00% | +100.0% |
Q3 2019 | $1,632,000 | +424.8% | 140,058 | +575.8% | 0.00% | – |
Q2 2019 | $311,000 | +46.7% | 20,724 | +71.1% | 0.00% | – |
Q1 2019 | $212,000 | +18.4% | 12,112 | 0.0% | 0.00% | – |
Q4 2018 | $179,000 | – | 12,112 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |